The Precision Peptide Company Inc.
BPC
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -417.50K | -1.03M | -2.45M | -446.00K | -222.10K |
| Total Depreciation and Amortization | -- | -- | 33.30K | 32.70K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.20K | 569.90K | 1.65M | -31.10K | -- |
| Change in Net Operating Assets | -257.60K | 33.00K | -347.80K | 417.50K | -173.00K |
| Cash from Operations | -631.00K | -430.10K | -1.12M | -26.80K | -395.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -51.20K | 52.40K | 290.00K | -489.60K | -161.50K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 167.10K | -- |
| Cash from Investing | -51.20K | 52.40K | 290.00K | -322.50K | -161.50K |
| Total Debt Issued | -- | -- | 100.00K | -- | -3.40K |
| Total Debt Repaid | -- | -- | -17.80K | -83.10K | -16.90K |
| Issuance of Common Stock | 1.30M | 20.00K | -- | 2.24M | 745.00K |
| Repurchase of Common Stock | -- | -- | -2.53M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 2.72M | -- | -- |
| Cash from Financing | 949.70K | 14.70K | 193.30K | 1.57M | 509.90K |
| Foreign Exchange rate Adjustments | -4.90K | -39.60K | 11.40K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 262.70K | -402.60K | -621.00K | 1.22M | -46.70K |